STD Laboratory-based Surveillance & Gonococcal Isolate Surveillance Project | CDC RFA PS14 140104CONT17

Opportunity Information: Apply for CDC RFA PS14 140104CONT17

The "STD Laboratory-based Surveillance and Gonococcal Isolate Surveillance Project" is a continuation funding opportunity from the Centers for Disease Control and Prevention (CDC), specifically within the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP). It is structured as a cooperative agreement, meaning CDC expects to have substantial involvement with recipients in carrying out the work, rather than providing hands-off support. The overall focus is public health: supporting laboratory-based surveillance activities for sexually transmitted diseases (STDs), with a particular emphasis on collecting and monitoring gonococcal isolates (Neisseria gonorrhoeae samples) that are essential for tracking trends such as antimicrobial resistance and other epidemiologic patterns.

This opportunity is categorized as a continuation award and is not an open competition. Funding is intended only for organizations that were previously funded under the earlier announcement CDC-RFA-PS14-1401 for the same project. In practical terms, this means new applicants are not eligible to apply; only existing, previously selected grantees can receive continued support under this specific continuation notice. The eligible applicant category is listed broadly as "Others," but the continuation-only restriction effectively narrows eligibility to prior awardees.

The funding opportunity number is CDC RFA PS14 140104CONT17, and it falls under CFDA 93.977, a CDC public health assistance listing commonly associated with STD prevention and control activities. The original closing date shown is September 7, 2016, and the posting (creation) date is May 5, 2016. The award ceiling is listed as 0, which typically indicates that a standard maximum amount was not specified in the public listing for this continuation action, often because continuation funding levels are determined by previously established budgets, available appropriations, recipient performance, and CDC program priorities rather than a single fixed cap. The listing also does not specify an expected number of awards, consistent with a continuation mechanism that is tied to an existing cohort of recipients rather than a new competitive cycle.

In summary, this grant opportunity supports ongoing, CDC-coordinated laboratory surveillance for STDs and continued gonococcal isolate surveillance work under a cooperative agreement model, but it is strictly limited to current awardees from the prior CDC-RFA-PS14-1401 project and is designed to maintain continuity of established surveillance capacity and data collection efforts rather than launch new, competitively selected projects.

• The Centers for Disease Control - NCHHSTP in the health sector is offering a public funding opportunity titled "STD Laboratory-based Surveillance & Gonococcal Isolate Surveillance Project" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.977.
• This funding opportunity was created on 2016-05-05.
• Applicants must submit their applications by 2016-09-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: Others.

Apply for CDC RFA PS14 140104CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: